BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22101402)

  • 1. DemQSAR: predicting human volume of distribution and clearance of drugs.
    Demir-Kavuk O; Bentzien J; Muegge I; Knapp EW
    J Comput Aided Mol Des; 2011 Dec; 25(12):1121-33. PubMed ID: 22101402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.
    Murad N; Pasikanti KK; Madej BD; Minnich A; McComas JM; Crouch S; Polli JW; Weber AD
    Drug Metab Dispos; 2021 Feb; 49(2):169-178. PubMed ID: 33239335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Mar; 101(3):1253-66. PubMed ID: 22170307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches for choosing feature selection and learning algorithms in quantitative structure-activity relationships (QSAR).
    Khan PM; Roy K
    Expert Opin Drug Discov; 2018 Dec; 13(12):1075-1089. PubMed ID: 30372648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state.
    Wajima T; Fukumura K; Yano Y; Oguma T
    J Pharm Pharmacol; 2003 Jul; 55(7):939-49. PubMed ID: 12906751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans.
    Mamada H; Iwamoto K; Nomura Y; Uesawa Y
    Mol Divers; 2021 Aug; 25(3):1261-1270. PubMed ID: 33569705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution.
    Gombar VK; Hall SD
    J Chem Inf Model; 2013 Apr; 53(4):948-57. PubMed ID: 23451981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-retention-pharmacokinetic relationship studies.
    Agatonovic-Kustrin S; Turner JV; Glass BD
    Drug Metab Lett; 2008 Apr; 2(2):130-7. PubMed ID: 19356082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Hakimiha N; Cronin MT
    J Pharm Pharmacol; 2004 Mar; 56(3):339-50. PubMed ID: 15025859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSPR models for the prediction of apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Dastmalchi S; Khavari-Khorasani T; Hakimiha N; Nokhodchi A
    Int J Pharm; 2006 Aug; 319(1-2):82-97. PubMed ID: 16698204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance.
    Ekins S; Obach RS
    J Pharmacol Exp Ther; 2000 Nov; 295(2):463-73. PubMed ID: 11046077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models.
    Sun L; Yang H; Li J; Wang T; Li W; Liu G; Tang Y
    ChemMedChem; 2018 Mar; 13(6):572-581. PubMed ID: 29057587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaussian processes: a method for automatic QSAR modeling of ADME properties.
    Obrezanova O; Csanyi G; Gola JM; Segall MD
    J Chem Inf Model; 2007; 47(5):1847-57. PubMed ID: 17602549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting drug metabolism and pharmacokinetics features of in-house compounds by a hybrid machine-learning model.
    Sasahara K; Shibata M; Sasabe H; Suzuki T; Takeuchi K; Umehara K; Kashiyama E
    Drug Metab Pharmacokinet; 2021 Aug; 39():100395. PubMed ID: 33991751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments of in silico predictions of intestinal absorption and oral bioavailability.
    Hou T; Li Y; Zhang W; Wang J
    Comb Chem High Throughput Screen; 2009 Jun; 12(5):497-506. PubMed ID: 19519329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.